Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI-528 (Enokizumab) in adults with atopic asthma
NCT00394654Phase 2Completed
- Sponsor
- MedImmune
- Start
- Nov 2006
- Primary completion
- Aug 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of enokizumab, sponsored by MedImmune. Started Nov 2006; status: completed.
02
Drugs
enokizumab
Beyond the preview
Go deeper on NCT00394654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394654.